hyaluronoglucosaminidase has been researched along with Bile Duct Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, D; Du, G; Fan, H; Jiang, Z; Jin, B; Ma, Y; Song, J; Wang, W; Xin, D; Yu, X; Zeng, Y; Zhai, X; Zhang, H; Zhang, X | 1 |
1 other study(ies) available for hyaluronoglucosaminidase and Bile Duct Neoplasms
| Article | Year |
|---|---|
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Databases, Genetic; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronoglucosaminidase; Male; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Signal Transduction; Tumor Burden | 2020 |